Zhang B - Search Results

1

Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy.

Li Z, Liu C, Li C, Wang F, Liu J, Zheng Z, Wu J, Zhang B. Li Z, et al. Among authors: zhang b. J Nanobiotechnology. 2021 Dec 14;19(1):421. doi: 10.1186/s12951-021-01172-0. J Nanobiotechnology. 2021. PMID: 34906155 Free PMC article.

2

Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects.

Jiang H, Li ZP, Tian GX, Pan RY, Xu CM, Zhang B, Wu JL. Jiang H, et al. Among authors: zhang b. Int J Nanomedicine. 2019 Mar 8;14:1789-1804. doi: 10.2147/IJN.S188971. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30880980 Free PMC article.

3

Therapeutic drugs and drug delivery systems targeting stromal cells for cancer therapy: a review.

Li Z, Zheng Z, Li C, Li Z, Wu J, Zhang B. Li Z, et al. Among authors: zhang b. J Drug Target. 2020 Aug-Sep;28(7-8):714-726. doi: 10.1080/1061186X.2020.1744157. Epub 2020 Mar 25. J Drug Target. 2020. PMID: 32183540 Review.

4

Acidic tumor microenvironment-sensitive liposomes enhance colorectal cancer therapy by acting on both tumor cells and cancer-associated fibroblasts.

Li C, Li Z, Gong X, Liu J, Zheng T, Wang F, Wu J, Zhang B. Li C, et al. Among authors: zhang b. Nanoscale. 2021 Jun 17;13(23):10509-10525. doi: 10.1039/d1nr01506k. Nanoscale. 2021. PMID: 34096957

5

Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy.

Zhao R, Liu J, Li Z, Zhang W, Wang F, Zhang B. Zhao R, et al. Among authors: zhang b, zhang w. Pharmaceutics. 2022 Jul 25;14(8):1541. doi: 10.3390/pharmaceutics14081541. Pharmaceutics. 2022. PMID: 35893797 Free PMC article. Review.

6

Bortezomib-loaded mixed micelles realize a "three-in-one" effect for enhanced breast cancer treatment.

Liu J, Xu X, Li Y, Xu J, Zhao R, Liu S, Wu J, Zhang L, Zhang B. Liu J, et al. Among authors: zhang l, zhang b. Biomater Sci. 2023 Jul 12;11(14):4890-4906. doi: 10.1039/d3bm00254c. Biomater Sci. 2023. PMID: 37306225

7

KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K/PD-L1 axis activity.

Jiang X, Xu Y, Ren H, Jiang J, Wudu M, Wang Q, Guan J, Su H, Zhang Y, Zhang B, Guo Y, Hu Y, Jiang L, Liu Z, Wang H, Cheng Y, Sun L, Qiu X. Jiang X, et al. Among authors: zhang b, zhang y. Cell Biosci. 2020 Nov 27;10(1):139. doi: 10.1186/s13578-020-00499-9. Cell Biosci. 2020. PMID: 33292627 Free PMC article.

8

Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1.

Li Q, Yang W, Zhang Q, Zhang D, Deng J, Chen B, Li P, Zhang H, Jiang Y, Li Y, Zhang B, Lin N. Li Q, et al. Among authors: zhang b, zhang q, zhang d, zhang h. Cancer Cell Int. 2024 Sep 13;24(1):315. doi: 10.1186/s12935-024-03489-w. Cancer Cell Int. 2024. PMID: 39272147 Free PMC article.

9

[Correlation of KLF4 and SPARC expression with the clinical characteristics of non-small cell lung cancer].

Zhang Z, Wang Z, Liu X, Shi M, Chen G, Zhang B, Li Z, Song L. Zhang Z, et al. Among authors: zhang b. Zhongguo Fei Ai Za Zhi. 2012 Dec;15(12):720-4. doi: 10.3779/j.issn.1009-3419.2012.12.05. Zhongguo Fei Ai Za Zhi. 2012. PMID: 23249717 Free PMC article. Chinese.

10

Identification of GBN5 as a molecular biomarker of pan-cancer species by integrated multi-omics analysis.

Guo Q, Zhong X, Dang Z, Zhang B, Yang Z. Guo Q, et al. Among authors: zhang b. Discov Oncol. 2025 Jan 25;16(1):85. doi: 10.1007/s12672-025-01840-9. Discov Oncol. 2025. PMID: 39862327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,989 results

Search Page

Filters